Alle verbonden artikelen

Side-effects of checkpoint inhibitor-based combination therapy.

Auteurs : Kourie HR, Klastersky J
Jaar : 2016
Journal : Curr Opin Oncol
Volume : 28
Pagina's : 306.13

16ème Rencontre Eveline Markiewicz sur les urgences et complications sévères chez le patient cancéreux. Revue Médicale de Bruxelles, 37 (2) :123-125 : 2016.37(2)

Auteurs : Sculier JP
Jaar : 2016
Journal : Rev Med Brux
Volume : 37(2
Pagina's : 123-5

Cancer drugs, survival and ethics: a critical look from the inside.

Auteurs : Piccart-Gebhart M, Pondé N
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000149

A Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early FDG PET-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.

Auteurs : Lalami Y, Garcia C, Flamen P, Ameye L, Paesmans M, Awada A
Jaar : 2016
Journal : Head Neck
Volume : 38(3)
Pagina's : 347-54

p53 Reactivation by PRIMA-1 Met (APR-246) sensitises V600E/K BRAF melanoma to vemurafenib.

Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Sales F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G
Jaar : 2016
Journal : Eur J Cancer
Volume : 55
Pagina's : 98-110

Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project.

Auteurs : Joye I, Macq G, Vaes E, Roels S, Lambrecht M, Pelgrims A, Bussels B, Vancleef A, Stellamans K, Scalliet P, Weytjens R, Christian N, Boulanger AS, Donnay L, Van Brussel S, Moretti L, Van den Bergh L, Van Eycken E, Debucquoy A, Haustermans K
Jaar : 2016
Journal : Radiother Oncol
Volume : 120(2)
Pagina's : 202-6

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al.

Auteurs : Cherny NI, Sullivan R, Dafni U, Bogaerts J, Kerst JM, Zielinski C, Piccart-Gebhart M, de Vries EG
Jaar : 2016
Journal : Ann Oncol
Volume : 27(11)
Pagina's : 2136-7

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013."

Auteurs : Rapoport B, Klastersky J, Raftopoulos H, Freifeld A, Aoun M, Zinner SH, Rolston KV
Jaar : 2016
Journal : Support Care Cancer
Volume : 24(7)
Pagina's : 2819-26

Rôle de corticostéroïdes dans le cancer de la prostate. Effet bénéfique ou néfaste ?

Auteurs : Martinez C, Sideris S, Roumeguere T, Van Velthoven R, Awada A, Costante G, Gil T
Jaar : 2016
Journal : Onco-Hémato
Volume : -
Pagina's : -

Cancer and fertility preservation: international recommendations from an expert meeting.

Auteurs : Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim HA Jr, Peccatori FA, Costa M, Revelli A, Salvagno F, Gennari A, Ubaldi FM, La Sala GB, De Stefano C, Wallace WH, Partridge AH, Anserini P
Jaar : 2016
Journal : BMC Med
Volume : 14
Pagina's : 1

NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.

Auteurs : Eyre TA, Clifford R, Bloor A, Boyle L, Roberts C, Cabes M, Collins GP, Devereux S, Follows G, Fox CP, Gribben J, Hillmen P, Hatton CS, Littlewood TJ, McCarthy H, Murray J, Pettitt AR, Soilleux E, Stamatopoulos B, Love SB, Wotherspoon A, Schuh A
Jaar : 2016
Journal : Br J Haematol
Volume : 175(1)
Pagina's : 43-54

Nasopharyngeal adenoid cystic carcinoma, a rare but highly challenging disease with unmet therapeutic needs: A case-report and review of the literature].

Auteurs : Afani L, Errihani H, Benchafai I, Lalami Y
Jaar : 2016
Journal : Cancer Radiother
Volume : 20(5)
Pagina's : 400-4

Quality assurance (QA) in radiotherapy : how important is it ? (ICACT)

Auteurs : Van Gestel D, Dragan T, Beauvois S
Jaar : 2016
Journal : Book
Volume : -
Pagina's : 44-48

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Auteurs : Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, de Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart-Gebhart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000127

Emerging Drugs Targeting Human Epidermal Growth Factor Receptor 2 (Her2) In The Treatment Of Breast Cancer.

Auteurs : Awada G, Gombos A, Aftimos P, Awada A
Jaar : 2016
Journal : Expert Opin Emerg Drugs
Volume : 21(1)
Pagina's : 91-101

Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.

Auteurs : Descamps G, Karaca Y, R Lechien J, Kindt N, Decaestecker C, Remmelink M, Larsimont D, Andry G, Hassid S, Rodriguez A, Khalife M, Journe F, Saussez S
Jaar : 2016
Journal : J Cancer Res Clin Oncol
Volume : 142(10)
Pagina's : 2185-96

A little help from steroids in oncology.

Auteurs : Lossignol D
Jaar : 2016
Journal : J Transl Int Med
Volume : 4(1)
Pagina's : 52-54

MULTIFOCALITY IN SPORADIC MEDULLARY THYROID CARCINOMA: AN INTERNATIONAL MULTICENTER STUDY.

Auteurs : Essig G Jr, Porter K, Schneider DF, Arpaia D, Lindsey SC, Busonero G, Fineberg D, Fruci B, Boelaert K, Smit J, Meijer J, Duntas LH, Sharma N, Costante G, Filetti S, Sippel RS, Biondi B Md, Topliss DJ, Pacini F, Maciel RM, Walz P, Kloos RT
Jaar : 2016
Journal : Thyroid
Volume : 26
Pagina's : 1563-72

The topography of mutational processes in breast cancer genomes.

Auteurs : Morganella S, Alexandrov LB, Glodzik D, Zou X, Davies H, Staaf J, Sieuwerts AM, Brinkman AB, Martin S, Ramakrishna M, Butler A, Kim HY, Borg Å, Sotiriou C, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Stunnenberg HG, Van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Sale J, Rada C, Stratton MR, Birney E, Nik-Zainal S
Jaar : 2016
Journal : Nat Commun
Volume : 7
Pagina's : 11383

Immune checkpoint inhibitors renal side effects and management.

Auteurs : Rassy EE, Kourie HR, Rizkallah J, Karak FE, Hanna C, Chelala DN, Ghosn M
Jaar : 2016
Journal : Immunotherapy
Volume : 8
Pagina's : 1417-1425